Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

New Method Devised for Treating Autoimmune Disease

By BiotechDaily International staff writers
Posted on 14 Jun 2012
Print article
Australian researchers have devised a new method that may regulate the body’s natural immune response, providing hope of a straightforward and effective treatment for autoimmune diseases.

The new approach involves increasing good regulating cells in the body, dissimilar to most current research which focuses on stopping “bad” (effector) cells, according to lead researcher Dr. Suzanne Hodgkinson, from University of New South Wales’ (UNSW) Faculty of Medicine (Sydney, Australia) and Liverpool Hospital.

The researchers triggered the body’s T-cell front-line defenses by injecting cell-signaling proteins called cytokines, in particular, cytokine interleukin-5 (II-5 cytokine). When T-regulatory cells are cultured in a way to make them specific to a particular protein, they develop receptors for the Il-5 cytokine. The Il-5 cytokine boost allows the body’s immune system to better regulate its response to disease without going into overdrive.

The team cloned II-5 cytokine and injected it into rats with the neurological condition Guillain-Barré syndrome. These rats recovered much faster, and if treated as a preventative, did not fall ill. The method has also shown potential in animals with multiple sclerosis, with kidney disease nephritis and trying to overcome organ transplantation rejection. “One of the nice things about this discovery is that it is one of the few treatments in the autoimmune world and in the transplantation world that works not by attacking the effector cells, but by increasing the good regulating cells. So it works in a very different way from almost every other treatment we've got available,” Dr. Hodgkinson said.

Il-5 injections could be more appetizing than inoculation by parasitic worms--another approach in regulating autoimmune disorders, according to the scientists. International research revealed that swallowing helminths parasites could regulate the immune system and increase T-cell production to fight disorders such as celiac disease and multiple sclerosis. The lack of the worms in guts in the developed world has been cited as a possible cause for the severe rise in autoimmune diseases in Western countries.

“The process we’ve developed may be the same process that the helminths kick off. When you get a helminths infestation, one of the changes in your immune response is an increase in cells called eosinophils and these cells make the cytokine interleukin-5,’ remarked Dr. Hodgkinson. “In this new treatment, it’s a matter of injecting the interleukin-5 and the body does the rest. It’s both safe and effective and we think inducing the immune response by injection may be more attractive to people than swallowing parasitic worms.”

The next phase of the research is to take the treatment to human trials, which could be undertaken within two to five years, Dr. Hodgkinson reported, whose study’s findings have has been published June 3, 2012, in the journal Blood.

Related Links:
University of New South Wales



Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.